Deciphering the role of mitochondrial cytochrome C oxidase subunit 4 in cardiac health and disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic pathways and preclinical concepts without new empirical human data.
PubMed 41763297 · doi:10.1016/j.lfs.2026.124295
What was done
The authors synthesized existing literature to review the physiological and pathological roles of mitochondrial cytochrome c oxidase subunit 4 (COX4) in the heart. The review focuses on the functions of its two isoforms (COX4-1 and COX4-2), their role in energy generation and reactive oxygen species regulation during cellular stress, their involvement in cardiovascular disease progression, and therapeutic compounds evaluated preclinically and clinically to modulate COX4.
What was found
The abstract provides no quantitative data or specific numerical metrics. Qualitatively, it notes that cardiac muscle cell volume is roughly 30% mitochondria and reports that a dynamic shift between COX4-1 and COX4-2 isoforms supports ATP generation through oxidative phosphorylation under stress. Persistent cellular stress impairs this dynamic isoform shift, leading to elevated reactive oxygen species production, compromised mitochondrial respiration, and impaired cardiac function.
Why it matters
This review organizes current mechanistic understanding of COX4 isoform regulation in myocardial bioenergetics, identifying COX4 modulation as a potential therapeutic target in cardiovascular disease management.
Limits
This is a narrative review presenting broad mechanistic overviews without primary empirical datasets, quantitative effect estimates, or systematic literature search methodology. Specific clinical outcomes, compound efficacies, and safety data are not detailed in the abstract.
Cited by
- context Mitochondria make up 70% of the volume of cardiac cells.